Loading...
A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Triple-negative breast cancer (TNBC) accounts for approximately 15% of all breast cancer cases. TNBC is highly aggressive and associated with poor prognosis. The present study aimed to compare gene expression between TNBC patients with pathological complete response (pCR) and those with not complete...
Na minha lista:
| Udgivet i: | Biosci Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Portland Press Ltd.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6509059/ https://ncbi.nlm.nih.gov/pubmed/30988073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20190414 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|